Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

$20m-$39.9m

Soft Robotics handles $23m series B
Harvard-founded industrial robot supplier Soft Robotics welcomed corporates Yamaha, Honeywell, Fanuc and Tekfen for its series B round.
ActionIQ packs $32m into series C
March Capital has led a round that boosted the overall funding for the Stanford-backed enterprise data management platform to $75m.
Treadwell steps up for $27m
Treadwell has launched with seed funding from Tio Bioventures to commercialise small molecule cancer drugs based on University Health Network research.
TScan eases to $35m series B close
Subsidiaries of Astellas and Novartis co-led a series B round that took Harvard's cancer treatment developer's overall funding to $60m.
ReadCoor scores $27m
Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.
Fusion ignites $20m
Fusion Pharmaceuticals has now raised $171m altogether to deliver cancer radiopharmaceuticals based on McMaster University research.
Inflammatix flags up $32m
Stanford-StartX Fund-backed Inflammatix received series C funding led by Grey Sky ahead of the European release of its acute infection diagnostics platform.
Virtual Incision sews up $20m
The colectomy-focused robotic surgical device developer has now assembled $51.7m having spun out from University of Nebraska Medical Center in 2006.

Other News

VectivBio begins with $35m
Inserm Transfer Initiative featured in the first round for VectivBio, a short bowel syndrome treatment developer spun out of Therachon following the latter's acquisition by Pfizer.
Eyevensys eventuates $30m
Paris Descartes University's gene therapy developer has raised $42.1m altogether following a series B featuring existing investors including Inserm Transfert Initiative.
Oxford Nanopore sequences $38.5m
The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.
Innophys muscles its way to series C round
Bic Camera, Brother Industries, Hi-Lex, Nac, TIS, Tokai and Towa were among the backers that supplied $32.3m for TUS spinout Innophys' series C funding.
ChromaCode cracks $28m series C
Caltech-founded ChromaCode has now raised $42.6m in all for its molecular diagnostics technology business.
Anyscale meets House Fund to unlock $20.6m
UC Berkeley-founded Anyscale has come out of stealth with the backing of investors including House Fund, Ant Financial and Intel Capital.

Editor's Picks

Tel Aviv partners with Tata
Tel Aviv University announces $20m commercialisation fund with Tata Industries.
UK graphene research nets $35m backing
Cell Medica raises $26.5m
Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.
Revolymer sticks to AIM in IPO
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
test reg

Login